QA: Vaccinex INC in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001205922_2023_Vaccinex_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'ComprehensiveIncomeNetOfTax'}

Graph

Absolute values for 0001205922, Vaccinex INC

  xvar xval
0 AssetsCurrent 7,478,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 189,000
3 remainder_Assets 310,000
4 LiabilitiesCurrent 2,537,000
5 LiabilitiesNoncurrent 247,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,185,705
9 ResearchAndDevelopmentExpense 13,331,331
10 remainder_Expenses 382,376
11 remainder_Revenues 550,324
12 remainder_NetIncome 330,813
13 remainder_ComprehensiveNetIncome -19,815,000
  yvar yval
0 Assets 7,977,000
1 Liabilities 2,784,000
2 Expenses 19,899,412
3 Revenues 550,324
4 StockholdersEquity 5,193,000
5 NetIncome -19,018,275
6 ComprehensiveNetIncome -28,925,775
7 BaseVar 25,678,274
8 EconomicCapitalRatiobeforeLimitedLiability -3.27
9 EconomicCapitalRatio 0.599

Edgar->Model Mapping

Feature Distribution

Change over Time